Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

8(88.9%)

Phase 1

1(11.1%)

9Total

N/A(8)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT04386941Not ApplicableCompleted

Greenlight Vaporization vs Xpeeda Vaporesection

Role: collaborator

NCT06192251Recruiting

Complete Lifestyle Medicine Intervention Program

Role: lead

NCT06192277Not ApplicableUnknown

Evaluation of a Direct Oral Penicillin Challenge in a Rural Community

Role: lead

NCT05519566Not ApplicableUnknown

The Accuracy of Pulsed Fluoroscopy Retrograde Urethrogram Vs the Traditional Retrograde Urethrogram In Diagnosing Urethral Stricture

Role: lead

NCT03196778Not ApplicableCompleted

Low Dose Hemi-body Radiation For Recurrent Prostate Cancer

Role: collaborator

NCT04793542Not ApplicableUnknown

Hot Water Immersion Therapy for Mental Health

Role: collaborator

NCT03357042Not ApplicableWithdrawn

Evaluation of a Physical Intervention for Persistent Post-Concussive Symptoms

Role: collaborator

NCT02265523Not ApplicableCompleted

Exercise and Cycle Ergometry Post TKA - A Randomized Controlled Trial

Role: collaborator

NCT03151187Not ApplicableUnknown

Evaluation of a Teaching Curriculum on Disruptive Behaviour Disorders

Role: collaborator

NCT00401089Phase 1Completed

Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia

Role: collaborator

All 10 trials loaded